UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from __________ to __________. Commission File Number: 001-41361 FORM 10-K AIMFINITY INVESTMENT CORP. I (Mark One) (Exact name of registrant as specified in its charter) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (425) 365-2933 (Reg ...

Core Viewpoint - Aimfinity Investment Corp. I (AIMA) has successfully approved its business combination with Docter Inc., a Taiwanese health technology company, with approximately 93.8% of votes in favor at the extraordinary general meeting of shareholders [1] Group 1: Business Combination Details - The business combination between AIMA and Docter was approved on March 27, 2025, at an extraordinary general meeting [1] - AIMA has extended the deadline for completing the business combination from March 28, 2025, to April 28, 2025, by depositing $55,823.80 into its trust account, equating to $0.05 per Class A ordinary share held by public shareholders [2] - AIMA's current charter allows for monthly extensions of the business combination deadline until October 28, 2025, with this being the third of nine available extensions [3] Group 2: Company Profiles - Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) focused on merging with high-growth potential businesses to facilitate their entry into capital markets [4] - Docter Inc. is a leading health technology company that develops innovative health monitoring solutions aimed at enhancing the accessibility and efficiency of global healthcare services [5] Group 3: Regulatory and Procedural Information - AIMA entered into a merger agreement with Docter on October 13, 2023, which involves a reincorporation merger and an acquisition merger [6] - AIMA has filed a final prospectus with the SEC on March 6, 2025, detailing the proposed transactions, and proxy materials have been mailed to shareholders [11]

Company Overview - Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands, focused on effecting mergers, share exchanges, asset acquisitions, and similar business combinations with various businesses or entities [3] - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [3] - Aimfinity will not complete its initial business combination with any target headquartered in China or conducting a majority of its business in China [3] Business Combination Update - The company announced an extension of the deadline to complete its initial business combination from February 28, 2025, to March 28, 2025, with a Monthly Extension Payment of $55,823.8, equating to $0.05 per Class A ordinary share held by public shareholders [1][2] - This extension is the second of nine monthly extensions allowed under the company's current charter, which permits monthly extensions from January 28, 2025, until October 28, 2025 [2] Merger Agreement - On October 13, 2023, Aimfinity entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [4] - The press release indicates that further information regarding the proposed business combination will be provided in a proxy statement/prospectus to be mailed to stockholders [4]

Wilmington, Delaware, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the "Company" or "AIMA") (NASDAQ:AIMAU), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from January 28, 2025 to February 28, 2025, on January 27, 2025, I-Fa Chang, manager of the sponsor of the Company, has deposited into its trust account (the "Trust Account") an ...

Core Points - Aimfinity Investment Corp. I held an Extraordinary General Meeting on January 9, 2025, to address matters typically discussed in an annual general meeting [1] - Shareholders approved an amendment to the Company's Charter, allowing an extension for the initial business combination until January 28, 2025, with the possibility of extending it up to nine additional months, totaling a potential deadline of October 28, 2025 [2][4] - The Company will require a Monthly Extension Payment of $0.05 for each public share for each one-month extension [2][4] - Mr. Kevin D. Vassily was re-elected as an independent director for a three-year term, and MaloneBailey, LLP was ratified as the independent registered public accounting firm for fiscal years 2023 and 2024 [3] Company Overview - Aimfinity Investment Corp. I is a blank check company incorporated in the Cayman Islands, focused on mergers, share exchanges, asset acquisitions, and similar business combinations [5] - The Company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [5] - Aimfinity Investment Corp. I will not complete a business combination with any target headquartered in China or conducting a majority of its business in China [5] Proposed Business Combination - On October 13, 2023, the Company entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [6]

Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the "Company" or "AIMA") (NASDAQ:AIMAU), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in connection with its extraordinary general meeting of shareholders that was previously adjourned from December 30, 2024 to January 9, 2025 (the "Meeting"), the Company has revised the terms and conditions in connection with the proposal to amend the Company's current charter (t ...

Wilmington, Delaware, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from December 28, 2024 to January 28, 2025, on December 27, 2024, I-Fa Chang, manager of the sponsor of the Company, has deposited into its trust account (the “Trust Account”) a ...

Company Overview - Aimfinity Investment Corp. I is a special purpose acquisition company incorporated in the Cayman Islands, focused on effecting mergers, share exchanges, asset acquisitions, and similar business combinations with various businesses or entities [3] - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [3] - Aimfinity will not complete its initial business combination with a target headquartered in China or conducting a majority of its business in China [3] Business Combination Update - The company announced an extension of the deadline to complete its initial business combination from November 28, 2024, to December 28, 2024, following a deposit of $60,000 into its trust account [1] - This extension marks the eighth of nine monthly extensions allowed under the company's current charter, which permits monthly extensions until January 28, 2025 [2] Merger Agreement - On October 13, 2023, Aimfinity entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [4] - The press release indicates that further details regarding the proposed business combination will be provided in a proxy statement/prospectus to be filed with the SEC [4]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________to __________ Commission File Number 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant as specified in its charter) Cayman Islands 98-1641561 (State o ...

IPO and Funding - The company completed its IPO on April 28, 2022, raising gross proceeds of $80.5 million from the sale of 8,050,000 units at $10.00 per unit[111]. - A total of $82.11 million from the IPO and private placement was deposited in a trust account for the benefit of public shareholders[111]. - The company has incurred losses since inception and currently has no revenue, relying on the sale of securities and loans for funding[113]. - The company has relied on the Sponsor for funding, with promissory notes issued for payments related to extensions[125]. - The company issued a promissory note to I-Fa Chang for up to $500,000 to be used for working capital, which is non-interest bearing and unsecured[138]. - The company has no off-balance sheet financing arrangements as of June 30, 2024[143]. Business Combination - On October 13, 2023, the company entered into a Business Combination Agreement with Docter Inc., which will result in the company being merged into a newly formed subsidiary[114]. - The Business Combination will involve the issuance of 6 million PubCo Ordinary Shares valued at $60 million to the Pre-Closing Target Stockholders[116]. - An additional 2.5 million Earnout Shares may be issued based on sales performance, with 1 million shares contingent on selling at least 30,000 devices in fiscal year 2024[117]. - The company has extended the deadline to consummate an initial business combination to April 28, 2024, with provisions for up to nine one-month extensions[121]. - The company has made three payments of $60,000 each for the Second Charter Amendment Monthly Extensions, extending the deadline to August 28, 2024[123]. - The board of directors of PubCo will consist of five directors post-business combination, with three designated by the Target and two by the Sponsor[120]. Financial Performance - For the three months ended June 30, 2024, the company reported a net income of $438,510, down from $640,387 in the same period of 2023, reflecting a decrease of approximately 31.5%[132]. - For the six months ended June 30, 2024, the company had a net income of $877,374, compared to $1,319,926 for the same period in 2023, indicating a decline of about 33.5%[133]. - As of June 30, 2024, the company held $35,683,308 in the Trust Account, which is invested in money market funds and U.S. Treasury Securities[135]. - The company incurred $5,117,607 in transaction costs related to the IPO, including $1,610,000 in underwriting fees and $2,817,500 in deferred underwriting fees[134]. - As of June 30, 2024, the company had cash of $4,895 and a working capital deficiency of $2,353,161[140]. - The company has not generated any operating revenues to date and does not expect to do so until after completing its Initial Business Combination[131]. - The company has substantial doubt about its ability to continue as a going concern if it cannot complete an Initial Business Combination by the Combination Deadline[142]. Use of Funds - The company intends to use funds held outside the Trust Account primarily for identifying and evaluating target businesses and performing due diligence[136].